SCHEMBL24933205

SCHEMBL24933205

Brc1ccc(C(c2cnco2)N2CCOCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
MGLL Q99685 1/20 0.40
GAA P10253 2/20 0.38
ACHE P22303 1/20 0.38
ALDH1A1 P00352 3/20 0.37
AKR1C3 P42330 2/20 0.36
OPRM1 P35372 2/20 0.36
OPRD1 P41143 2/20 0.36
OPRK1 P41145 2/20 0.36
OPRL1 P41146 2/20 0.36
P2RX7 Q99572 1/20 0.36
CYP19A1 P11511 1/20 0.36
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
RECQL P46063 1/20 0.35
CYP1A1 P04798 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933207 0.77 ESR2 (0.35) ACHEALDH1A1P2RX7KDM4EMEN1
SCHEMBL24723410 0.68 MGLL (0.49) LMNAMGLLALDH1A1AKR1C3KDM4E
SCHEMBL1927515 0.68 LTA4H (0.49) MGLLACHEALDH1A1OPRM1KDM4E
SCHEMBL1927983 0.68 LTA4H (0.49) MGLLACHEALDH1A1OPRM1KDM4E
SCHEMBL30206304 0.68 LTA4H (0.49) MGLLACHEALDH1A1OPRM1KDM4E
SCHEMBL1927517 0.68 LTA4H (0.49) MGLLACHEALDH1A1OPRM1KDM4E
SCHEMBL24933204 0.68 GAA (0.47) GAACYP19A1MEN1KMT2ASMN1; SMN2
SCHEMBL16995098 0.67 ALDH1A1 (0.49) ACHEALDH1A1P2RX7KDM4EMEN1
SCHEMBL16995129 0.67 DPP4 (0.48) LMNAALDH1A1P2RX7KDM4EMEN1
SCHEMBL7296589 0.65 ALDH1A1 (0.71) MGLLACHEALDH1A1OPRL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed